top of page

Genome Editing in Human iPS Cells to Study and Cure Disease

Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More


2024. 4. 20. Open labs for graduate and undergraduate students.

2024. 4. 27. Tokyo Science Festival (Hosting an event for kids to perform DNA agarose gel electrophoresis)

2024. 6. 2-4. 8th International Update on Fabry Disease @ Hamburg (Talk)

2024. 6. 17-19. 9th Annual Meeting of The Japanese Society for Genome Editing

2024. 7. 24-27. NEURO2024@Fukuoka Convention Center

2024. 11. 27-29. MBSJ@Fukuoka Convention Center

2024. 12. 5. Seminar at Ome Nursing School


bottom of page